Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 31, 1899-1902, December 1, 1971]
© 1971 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sizaret, P. P.
Right arrow Articles by Princler, G. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sizaret, P. P.
Right arrow Articles by Princler, G. L.

Quantitation of Human {alpha}-Fetoprotein by Electroimmunodiffusion

Philippe P. Sizaret, K. Robert McIntire and Gerald L. Princler

International Agency for Research on Cancer, Lyon, France [P. P. S.], and Laboratory of Cell Biology, National Cancer Institute, Bethesda, Maryland 20014 [K. R. M., G. L. P.]

The association of {alpha}-1-fetoprotein in the serum of patients with primary hepatocellular carcinoma provides another possible parameter for both diagnosis and evaluation of the disease process. A technique for the quantitative measurement of this protein has been devised that uses the method of electroimmunodiffusion. This technique has greater sensitivity and is faster than radial diffusion with antibody in agar. Serums from 75 patients with hepatomas were measured for {alpha}-fetoprotein, and these varied from 0.35 to 4950 {varepsilon}g/ml.

Received 5/17/71. Accepted 7/20/71.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1971 by the American Association for Cancer Research.